Abstract | PURPOSE: METHODS: Twenty patients with MGD were prospectively randomized and assigned into 2 groups. The patients were instructed to use either NAC 5% or a topical steroid- antibiotic combination, betamethasone 0.1%- sulfacetamide sodium 10%, topically 4 times a day for a month. All patients were instructed to apply lid hygiene once daily. RESULTS: One month of topical therapy provided statistically significant improvements in fluorescein break-up time and Schirmer scores as compared with the initial study visit in both groups (P≤0.001). Significant improvements for the symptoms of ocular burning, itching, and intermittent filmy or blurred vision were noted in both groups at 1 month as compared with 1 day (P<0.05). Considering these rates, there was no significant difference between the groups (P>0.05). None of the patients developed an allergic reaction to the medications, and intraocular pressure measurements were within the normal limits in both groups. CONCLUSION:
|
Authors | Ilknur Akyol-Salman, Sedat Azizi, Uğur Yilmaz Mumcu, Orhan Ateş, Orhan Baykal |
Journal | Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics
(J Ocul Pharmacol Ther)
Vol. 28
Issue 1
Pg. 49-52
(Feb 2012)
ISSN: 1557-7732 [Electronic] United States |
PMID | 21751879
(Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
|
Chemical References |
- Anti-Infective Agents
- Drug Combinations
- Glucocorticoids
- Sulfacetamide
- Betamethasone
- Acetylcysteine
|
Topics |
- Acetylcysteine
(administration & dosage, therapeutic use)
- Administration, Topical
- Adolescent
- Adult
- Anti-Infective Agents
(administration & dosage, therapeutic use)
- Betamethasone
(administration & dosage, therapeutic use)
- Drug Combinations
- Eyelid Diseases
(drug therapy, pathology)
- Female
- Glucocorticoids
(administration & dosage, therapeutic use)
- Humans
- Intraocular Pressure
(drug effects)
- Male
- Meibomian Glands
(drug effects, pathology)
- Middle Aged
- Prospective Studies
- Sulfacetamide
(administration & dosage, therapeutic use)
- Treatment Outcome
- Young Adult
|